DVA Revenue Flow
Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.
- 2026-06-30: Revenue $3.55B; Revenue including tax (m); Income tax $91.79M; Net income $265.40M.
- 2026-03-31: Revenue $3.42B; Revenue including tax (m); Income tax $66.20M; Net income $197.53M.
- 2025-12-31: Revenue $3.62B*; Revenue including tax (m); Income tax $76.73M*; Net income $566.13M*.
- 2025-09-30: Revenue $3.42B; Revenue including tax (m); Income tax $68.55M; Net income $150.33M.
Consolidation item
Separate filed amounts; connecting flows are not established. Components and totals may overlap.
Health Care Organization Revenue Sources
Separate filed amounts; connecting flows are not established. Components and totals may overlap.
Segment
Separate filed amounts; connecting flows are not established. Components and totals may overlap.
Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.
Historical revenue and expense breakdown
Revenue and expense 3 month
| Period end | Revenue | Revenue including tax | Income tax | Net income |
|---|---|---|---|---|
| 2026-06-30 | $3.55B | (m) | $91.79M | $265.40M |
| 2026-03-31 | $3.42B | (m) | $66.20M | $197.53M |
| 2025-12-31 | $3.62B* | (m) | $76.73M* | $566.13M* |
| 2025-09-30 | $3.42B | (m) | $68.55M | $150.33M |
| 2025-06-30 | $3.38B | (m) | $93.71M | $199.34M |
| 2025-03-31 | $3.22B | (m) | $54.12M | $162.92M |
| 2024-09-30 | $3.26B | (m) | $77.67M | $214.69M |
| 2024-06-30 | $3.19B | (m) | $71.69M | $222.68M |
| 2024-03-31 | $3.07B | (m) | $65.81M | $239.65M |
| 2023-09-30 | $3.12B | (m) | $68.85M | $246.63M |
| 2023-06-30 | $3.00B | (m) | $48.82M | $178.69M |
| 2023-03-31 | $2.87B | (m) | $43.95M | $115.55M |
| 2022-09-30 | $2.95B | (m) | $42.52M | $105.37M |
| 2022-06-30 | $2.93B | (m) | $64.23M | $224.81M |
| 2022-03-31 | $2.82B | (m) | $57.01M | $162.12M |
| 2021-09-30 | $2.94B | (m) | $74.70M | $259.75M |
| 2021-06-30 | $2.92B | (m) | $81.31M | $293.82M |
| 2021-03-31 | $2.82B | (m) | $85.21M | $237.40M |
| 2020-12-31 | $2.91B | (m) | (m) | $173.77M |
| 2020-09-30 | $2.92B | (m) | $65.79M | $158.67M |
| 2020-06-30 | $2.88B | (m) | $83.21M | $201.60M |
| 2020-03-31 | $2.84B | (m) | $91.56M | $239.59M |
| 2019-12-31 | $2.90B | (m) | (m) | $244.87M |
| 2019-09-30 | $2.90B | $2.78B | $65.25M | $143.27M |
| 2019-06-30 | $2.84B | $2.73B | $75.94M | $273.55M |
| 2019-03-31 | $2.74B | $2.64B | $56.75M | $149.29M |
| 2018-12-31 | $2.82B | (m) | (m) | -$149.77M |
| 2018-09-30 | $2.85B | $2.67B | $52.05M | -$136.80M |
| 2018-06-30 | $2.89B | $2.72B | $83.87M | $267.28M |
| 2018-03-31 | $2.85B | $2.59B | $70.74M | $178.69M |
| 2017-12-31 | $2.78B | (m) | (m) | $303.40M |
| 2017-09-30 | $2.77B | $2.56B | $90.55M | -$214.48M |
| 2017-06-30 | $2.70B | $2.49B | $101.92M | $127.00M |
| 2017-03-31 | $2.63B | (m) | $281.67M | $447.70M |
| 2016-12-31 | (m) | (m) | (m) | $157.73M |
| 2016-09-30 | (m) | (m) | $104.30M | $571.33M |
| 2016-06-30 | (m) | (m) | $134.89M | $53.38M |
| 2016-03-31 | (m) | (m) | $126.82M | $97.43M |
| 2015-12-31 | (m) | (m) | (m) | -$6.00M |
| 2015-09-30 | (m) | (m) | $147.06M | $215.87M |
| 2015-06-30 | (m) | (m) | $122.76M | $170.48M |
| 2015-03-31 | (m) | (m) | -$85.93M | -$110.62M |
| 2014-12-31 | (m) | (m) | (m) | $208.02M |
| 2014-09-30 | (m) | (m) | $116.63M | $184.12M |
| 2014-06-30 | (m) | (m) | $100.89M | $147.68M |
| 2014-03-31 | (m) | (m) | $124.85M | $183.29M |
| 2013-12-31 | (m) | (m) | (m) | $212.28M |
| 2013-09-30 | (m) | (m) | $100.93M | $136.63M |
| 2013-06-30 | (m) | (m) | $129.19M | $254.38M |
| 2013-03-31 | (m) | (m) | $15.14M | $30.16M |
| 2012-12-31 | (m) | (m) | (m) | $155.84M |
| 2012-09-30 | (m) | (m) | $98.65M | $144.72M |
| 2012-06-30 | (m) | (m) | $67.74M | $95.34M |
| 2012-03-31 | (m) | (m) | $95.56M | $140.12M |
| 2011-12-31 | (m) | (m) | (m) | $148.12M |
| 2011-09-30 | (m) | (m) | $94.20M | $135.36M |
| 2011-06-30 | (m) | (m) | $66.87M | $100.02M |
| 2011-03-31 | (m) | (m) | $62.96M | $94.50M |
| 2010-12-31 | (m) | (m) | (m) | $69.02M |
| 2010-09-30 | (m) | (m) | $75.04M | $119.39M |
| 2010-06-30 | (m) | (m) | $71.43M | $107.85M |
| 2010-03-31 | (m) | (m) | $73.91M | $109.42M |
| 2009-12-31 | (m) | (m) | (m) | $109.72M |
| 2009-09-30 | (m) | (m) | $74.19M | $110.93M |
| 2009-06-30 | (m) | (m) | $70.51M | $105.82M |
| 2009-03-31 | (m) | (m) | $64.78M | $96.21M |
| 2008-09-30 | (m) | (m) | $62.01M | $93.91M |
| 2008-06-30 | (m) | (m) | $58.27M | $94.95M |
Revenue and expense 6 month
| Period end | Revenue | Revenue including tax | Income tax | Net income |
|---|---|---|---|---|
| 2026-06-30 | $6.97B | (m) | $157.99M | $462.93M |
| 2025-06-30 | $6.60B | (m) | $147.82M | $362.25M |
| 2024-06-30 | $6.26B | (m) | $137.49M | $462.32M |
| 2023-06-30 | $5.87B | (m) | $92.77M | $294.24M |
| 2022-06-30 | $5.74B | (m) | $121.24M | $386.93M |
| 2021-06-30 | $5.74B | (m) | $166.52M | $531.22M |
| 2020-06-30 | $5.72B | (m) | $174.77M | $441.19M |
| 2019-06-30 | $5.59B | $5.37B | $132.68M | $422.84M |
| 2018-06-30 | $5.74B | $5.31B | $154.60M | $445.96M |
| 2017-06-30 | $5.33B | $4.92B | $383.58M | $574.70M |
| 2016-06-30 | (m) | (m) | $261.71M | $150.82M |
| 2015-06-30 | (m) | (m) | $36.83M | $59.86M |
| 2014-06-30 | (m) | (m) | $225.74M | $330.97M |
| 2013-06-30 | (m) | (m) | $144.34M | $284.54M |
| 2012-06-30 | (m) | (m) | $163.30M | $235.46M |
| 2011-06-30 | (m) | (m) | $129.83M | $194.52M |
| 2010-06-30 | (m) | (m) | $145.34M | $217.28M |
| 2009-06-30 | (m) | (m) | $135.29M | $202.03M |
| 2008-06-30 | (m) | (m) | $113.84M | $181.88M |
Revenue and expense 9 month
| Period end | Revenue | Revenue including tax | Income tax | Net income |
|---|---|---|---|---|
| 2025-09-30 | $10.02B | (m) | $216.38M | $512.59M |
| 2024-09-30 | $9.52B | (m) | $215.17M | $677.01M |
| 2023-09-30 | $8.99B | (m) | $161.62M | $540.87M |
| 2022-09-30 | $8.69B | (m) | $163.76M | $492.30M |
| 2021-09-30 | $8.67B | (m) | $241.22M | $790.98M |
| 2020-09-30 | $8.65B | (m) | $240.56M | $599.87M |
| 2019-09-30 | $8.49B | $8.15B | $197.94M | $566.11M |
| 2018-09-30 | $8.58B | $7.98B | $206.65M | $309.17M |
| 2017-09-30 | $8.10B | $7.48B | $474.13M | $360.22M |
| 2016-09-30 | (m) | (m) | $366.01M | $722.15M |
| 2015-09-30 | (m) | (m) | $183.89M | $275.73M |
| 2014-09-30 | (m) | (m) | $342.37M | $515.09M |
| 2013-09-30 | (m) | (m) | $245.27M | $421.17M |
| 2012-09-30 | (m) | (m) | $261.94M | $380.18M |
| 2011-09-30 | (m) | (m) | $224.03M | $329.88M |
| 2010-09-30 | (m) | (m) | $220.19M | $336.66M |
| 2009-09-30 | (m) | (m) | $209.49M | $312.96M |
| 2008-09-30 | (m) | (m) | $175.85M | $275.80M |
Revenue and expense 12 month
| Period end | Revenue | Revenue including tax | Income tax | Net income |
|---|---|---|---|---|
| 2025-12-31 | $13.64B | (m) | $293.11M | $1.08B |
| 2024-12-31 | $12.82B | (m) | $279.66M | $1.25B |
| 2023-12-31 | $12.14B | (m) | $220.12M | $956.98M |
| 2022-12-31 | $11.61B | (m) | $198.09M | $781.64M |
| 2021-12-31 | $11.62B | (m) | $306.73M | $1.21B |
| 2020-12-31 | $11.55B | $11.04B | $313.93M | $773.64M |
| 2019-12-31 | $11.39B | $10.92B | $279.63M | $810.98M |
| 2018-12-31 | $11.40B | $10.71B | $258.40M | $159.39M |
| 2017-12-31 | $10.88B | $10.09B | $323.86M | $663.62M |
| 2016-12-31 | $10.71B | $9.73B | $431.76M | $879.87M |
| 2015-12-31 | (m) | (m) | $207.51M | $269.73M |
| 2014-12-31 | (m) | (m) | $446.34M | $723.11M |
| 2013-12-31 | (m) | (m) | $381.01M | $633.45M |
| 2012-12-31 | (m) | (m) | $359.85M | $536.02M |
| 2011-12-31 | (m) | (m) | $325.29M | $478.00M |
| 2010-12-31 | (m) | (m) | $258.87M | $405.68M |
| 2009-12-31 | (m) | (m) | $278.21M | $422.68M |
| 2008-12-31 | (m) | (m) | $235.47M | $374.16M |
| 2007-12-31 | (m) | (m) | $245.58M | $381.78M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |